Tuesday, June 9, 2020

Recon: Royalty Pharma targets $2B IPO; Judge sides with AbbVie in Humira patent thicket suit Posted 09 June 2020 | By Michael Mezher

https://www.raps.org/news-and-articles/news-articles/2020/6/recon-royalty-pharma-targets-2b-ipo-judge-sides-wi

No comments: